Clal Insurance’s Eloxx Pharmaceuticals, Inc. Common Stock ELOX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-13,526
| Closed | -$16K | – | 147 |
|
|
2023
Q4 | $16K | Hold |
13,526
| – | – | ﹤0.01% | 117 |
|
|
2023
Q3 | $65K | Sell |
13,526
-1,100
| -8% | -$6.16K | ﹤0.01% | 119 |
|
|
2023
Q2 | $57K | Hold |
14,626
| – | – | ﹤0.01% | 138 |
|
|
2023
Q1 | $37K | Hold |
14,626
| – | – | ﹤0.01% | 137 |
|
|
2022
Q4 | $27K | Buy |
14,626
+1
| +0% | +$5 | ﹤0.01% | 147 |
|
|
2022
Q3 | $99K | Hold |
14,625
| – | – | ﹤0.01% | 145 |
|
|
2022
Q2 | $158K | Hold |
14,625
| – | – | ﹤0.01% | 152 |
|
|
2022
Q1 | $328K | Hold |
14,625
| – | – | ﹤0.01% | 152 |
|
|
2021
Q4 | $413K | Hold |
14,625
| – | – | ﹤0.01% | 155 |
|
|
2021
Q3 | $954K | Hold |
14,625
| – | – | 0.01% | 152 |
|
|
2021
Q2 | $1.16M | Hold |
14,625
| – | – | 0.01% | 146 |
|
|
2021
Q1 | $1.94M | Hold |
14,625
| – | – | 0.02% | 134 |
|
|
2020
Q4 | $2.17M | Hold |
14,625
| – | – | 0.03% | 99 |
|
|
2020
Q3 | $1.54M | Hold |
14,625
| – | – | 0.03% | 97 |
|
|
2020
Q2 | $1.77M | Hold |
14,625
| – | – | 0.04% | 97 |
|
|
2020
Q1 | $1.15M | Buy |
14,625
+14,517
| +13,442% | +$2.36M | 0.03% | 91 |
|
|
2019
Q4 | $585K | Sell |
108
-14,517
| -99% | -$2.93M | 0.63% | 43 |
|
|
2019
Q3 | $2.64M | Sell |
14,625
-250
| -2% | -$71.1K | 0.06% | 81 |
|
|
2019
Q2 | $5.93M | Buy |
+14,875
| New | +$6.26M | 0.14% | 65 |
|
Other funds holding ELOX
Clal Insurance's ELOX Position: Q1 2024 in Review
Clal Insurance sold out of Eloxx Pharmaceuticals, Inc. Common Stock (ELOX) in Q1 2024, closing a stake of 13,526 shares — an estimated $16K sold.
Clal Insurance first reported a position in ELOX in Q2 2019 and held it in 19 quarters. The position peaked at $5.93M in Q2 2019. 1 fund tracked by Wall St. Rank holds ELOX as of Q1 2024.
- Clal Insurance reported no remaining Eloxx Pharmaceuticals, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
- Clal Insurance sold 13,526 Eloxx Pharmaceuticals, Inc. Common Stock shares in Q1 2024, an estimated $16K.
- Clal Insurance first reported a position in Eloxx Pharmaceuticals, Inc. Common Stock in Q2 2019 and held it in 19 quarters.
- Clal Insurance's Eloxx Pharmaceuticals, Inc. Common Stock position peaked at $5.93M in Q2 2019.
- 1 fund tracked by Wall St. Rank held Eloxx Pharmaceuticals, Inc. Common Stock as of Q1 2024.
Based on Clal Insurance's 13F filing for Q1 2024, filed 9 May 2024.